We use Next-Generation Sequencing (NGS) to accelerate drug discovery by uncovering disease genetics, identifying key targets, mutations, and biomarkers. This informs the development of safer, more effective therapies and enhances patient stratification in trials, improving efficiency and speeding up drug development. Our NGS technology advances personalized medicine, tailoring treatments to genetic profiles, boosting outcomes, and reducing adverse reactions.